Huprine Y – Tryptophan heterodimers with potential implication to Alzheimer’s disease treatment-Reference-Cited by-同舟云学术

Huprine Y – Tryptophan heterodimers with potential implication to Alzheimer’s disease treatment

Published:2021-07 Issue: Volume:43 Page:128100
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Mezeiova Eva,Hrabinova Martina,Hepnarova Vendula,Jun Daniel,Janockova Jana^ORCID,Muckova Lubica^ORCID,Prchal Lukas,Kristofikova Zdena,Kucera Tomas,Gorecki Lukas,Chalupova Katarina,Kunes Jiri,Hroudova Jana,Soukup Ondrej^ORCID,Korabecny Jan^ORCID

Funder

Czech Science Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference71 articles.

1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet Lond Engl. 2006;368:387–403. https://doi.org/10.1016/S0140-6736(06)69113-7.

2. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine;Zemek;Expert Opin Drug Saf,2014

3. Disease-modifying therapies in Alzheimer's disease;Salloway;Alzheimers Dement J Alzheimers Assoc,2008

4. Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease;Prati;Mol Basel Switz,2016

5. Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics;Rosini;Future Med Chem,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease;Chemical Biology & Drug Design;2024-02

2. Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond;European Journal of Medicinal Chemistry;2024-01

3. Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease;International Journal of Molecular Sciences;2023-05-23

4. Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy;European Journal of Medicinal Chemistry;2022-11

5. Tryptophan-derived Alkaloids from Hedera rhombea Fruits and Their Butyrylcholinesterase Inhibitory Activity;Natural Product Sciences;2022-09-30